MAPT and Alzheimer disease: Overall, our results showed that PET with [18-F]AV1451 tau-specific tracer can discriminate FTLD-non-AD and FTLD-AD cohort by its high specificity to paired-helical filaments seen in AD, and is associated with a higher global PET signal in the FTLD-AD group.